Downregulation of integrin-linked kinase inhibits epithelial-to-mesenchymal transition and metastasis in bladder cancer cells

Integrin-linked kinase (ILK) is a multifunctional serine/threonine kinase in cytoplasm. Recent studies showed that cancer patients with increased ILK expression had low survival, poor prognosis and increased metastasis. Although the causes of ILK overexpression remain to be fully elucidated, accumulating evidence suggests that its oncogenic capacity derives from its regulation of several downstream targets that provide cells with signals that promote proliferation, survival and migration. However, the mechanisms underlying tumor metastasis by ILK is still not fully understood. Epithelial–mesenchymal transition (EMT) is a critical event of cancer cells that triggers invasion and metastasis. We recently reported that knockdown of ILK inhibited the growth and induced apoptosis in human bladder cancer cells. Therefore, we postulate that ILK might involve in EMT. Here we further investigate the function of ILK with RNA interference in bladder cancer cells. Knockdown of ILK impeded an EMT with low Vimentin, Snail, Slug and Twist as well as high E-cadherin expression in vivo and vitro. In addition, we found that knockdown of ILK inhibited cell proliferation, migration and invasion as well as changed cell morphology, adhesion and rearranged cytoskeleton in vitro. We also demonstrated that ILK siRNA inhibited phosphorylation of downstream signaling targets Akt and GSK3β, increased expression of nm23-H1, as well as reduced expression of MMP-2 and MMP-9 in vivo and vitro. Furthermore, downregulation of ILK could increase expression of Ribonuclease inhibitor (RI), an important acidic cytoplasmic protein with many functions. Finally, the effects of ILK siRNA on bladder cancer cell phenotype and invasiveness translate into suppression for tumorigenesis and metastasis in vivo. Taken together, our findings highlight that ILK signaling pathway plays a novel role in the development of bladder cancer through regulating EMT. ILK could be a promising diagnostic marker and therapeutic target for bladder cancer.     

Knockdown of ribonuclease inhibitor expression with siRNA in non-invasive bladder cancer cell line BIU-87 promotes growth and metastasis potentials

Human ribonuclease inhibitor (RI) is a cytoplasmic acidic protein. RI is constructed almost entirely of leucine-rich repeats, which might be involved in some unknown biological functions like other structurally similar proteins besides inhibiting RNase A and angiogenin activities. Our previous experiments demonstrated that up-regulating RI might effectively inhibit some tumor growth and metastasis. However, the down-regulating RI influence on the tumor does not have any report until now, the mechanisms underlying antitumor of RI have not been fully understood. In this study, the efficient RNA interferences of RI were constructed using a plasmid vector and identified with RT-PCR, Western blot and Immunocytochemistry, then were transfected into non-invasive bladder cancer BIU-87 cells. We demonstrated that knockdown RI expression in BIU-87 cells could obviously change the cell morphology, rearrange the microfilaments and extend the lamellipodia, as well as enhance proliferation, increase migration, invasion and matrix metalloprotease level, and also reduce adhesion in vitro. BALB/C nude mice that were injected with the BIU-87 cells transfected RI siRNA showed a significant facilitation of the tumor with heavier tumor weight, higher density of microvessels, lower nm23-H1 and E-Cadherin expressions than those in the control group. Taken together, these experiments suggest that knockdown of RI could promote growth and metastasis potentials of BIU-87 cells. Our present findings reveal the novel mechanism that anti-tumor effect of RI is also involved in suppressing growth and metastasis, besides antiangiogenesis. The results show that RI may be a therapeutic target protein for bladder cancer and may be of biological importance.     

Silencing USP22 by asymmetric structure of interfering RNA inhibits proliferation and induces cell cycle arrest in bladder cancer cells

The ubiquitin specific peptidase 22 (USP22) is a positive regulator of the growth of tumors. However, little is known about the impact of USP22 knockdown on the growth of human bladder cells. In the present study, we designed a series of asymmetric interfering RNAs (aiRNAs) and compared the efficacy of aiRNA and conventional symmetric interfering RNA (siRNA) in the silencing of USP22 expression and the growth of human bladder EJ cells in vitro and in vivo. In comparison with transfection with the USP22-specific siRNA, transfection with 15/21 aiRNA was more potent in down-regulating the USP22 expression and inhibiting EJ cell proliferation in vitro. Furthermore, transfection with 15/21 aiRNA induced higher frequency of EJ cells arrested at the G0/G1 phases, but did not trigger EJ cell apoptosis. Moreover, transfection with either the siRNA or 15/21 aiRNA up-regulated the expression of p53 and p21, but down-regulated the expression of cyclin E and Mdm2 in EJ cells. The up-regulated p53 expression induced by the specific siRNA or aiRNA was abrogated by induction of Mdm2 over-expression. In addition, treatment with the specific siRNA or aiRNA inhibited the growth of implanted human bladder tumors in mice and the aiRNA had more potent anti-tumor activity in vivo. Therefore, our data suggest that knockdown of USP22 expression by the aiRNA may down-regulate the expression of Mdm2 and cyclin E, resulting in the up-regulated expression of p53 and p21 and leading to cell cycling arrest and inhibition of human bladder EJ cell proliferation. Our findings indicate that the USP22-specific aiRNA may be a novel approach for the intervention of human bladder tumors.     

RNA干扰PLCε诱导人膀胱癌BIU-87细胞凋亡的实验研究

目的探讨以RNA干扰沉默人源磷脂酶Ce(phospholipase Cepsilon,PLCε)基因表达后诱导人膀胱癌细胞株BIU-87细胞凋亡的作用和机制。方法脂质体介导重组阳性质粒pGenesil-PLCε(以下简称P)和阴性质粒pGenesil-NP(以下简称NP)转染BIU-87细胞48h后,用RT-PCR和Western blot检测转染前后PLCεmRNA和蛋白表达,流式细胞术检测细胞周期和细胞凋亡率,电镜观察细胞形态改变。结果转染P质粒后可明显抑制PLCεmRNA和蛋白表达水平,抑制率分别为78.7%和76.6%;流式细胞术显示P质粒转染组细胞周期发生改变呈明显G0/G1期阻滞,并出现亚二倍体凋亡峰,细胞凋亡率增加(P0.05);电镜观察P质粒转染组细胞可见凋亡小体。结论:RNA干扰沉默PLCε基因表达可诱导膀胱癌BIU-87细胞凋亡,其作用机制与细胞周期分布的改变有关。     

The effects on cell growth and chemosensitivity by livin RNAi in non-small cell lung cancer

Livin is highly expressed in most tumor tissues and could inhibit the tumor cells apoptosis. Knockdown of endogenous livin expression in non-small cell lung cancer (NSCLC) cells could inhibit cell growth. But it is still unclear if knockdown of endogenous livin expression combined with conventional chemotherapy could play a positive role in NSCLC treatment. In this article, the efficient RNA interferences (RNAi) of livin were constructed, and then we transfected them into A549 cells and 103H cells to study their influence on cell cycle and apoptosis index. At last, we detected the cell's sensitivity to conventional chemotherapeutic drugs after knockdown endogenous livin expression in A549 cells and 103H cells. Our results showed that knockdown livin expression could inhibit cell growth and induce apoptosis in A549 cells and 103H cells. A549 cells and 103H cells had an increased chemosensitivity to adriamycin and cisplatin after transfection of livin RNAi constructs. The results indicated that cell cycle redistribution and increased apoptosis index after knockdown livin expression might provide the main explanation for the enhanced chemosensitivity. Proper combination of livin RNAi and some conventional chemotherapeutic drugs may entail potential benefits in the treatment of NSCLC.     

Angiopoietin-2, an angiogenic regulator, promotes initial growth and survival of breast cancer metastases to the lung through the integrin-linked kinase (ILK)-AKT-B cell lymphoma 2 (Bcl-2) pathway

The early onsets of breast cancer metastasis involve cell retention, survival, and resistant to apoptosis and subsequent growth at target vascular beds and tissues in distant organs. We previously reported that angiopoietin-2 (Ang2), an angiogenic regulator stimulates MCF-7 breast tumor metastasis from their orthotopic sites to distant organs through the α(5)β(1) integrin/integrin-linked kinase (ILK)/Akt pathway. Here, by using an experimental tumor metastasis model and in vitro studies, we further dissect the underlying mechanism by which Ang2 promotes the initial growth and survival of MCF-7 breast cancer metastasis in the lung of animals. We show that Ang2 increases cell survival and suppresses cell apoptosis through ILK-induced phosphorylation of Akt1, Akt2, and up-regulation of Bcl-2 in breast cancer cells. Inhibition of ILK, Akt1, and Akt2, and their effector Bcl-2 diminishes Ang2-stimulated breast cancer cell survival and Ang2-attenuated apoptosis in vitro, and initial survival and growth of breast cancer metastasis in the lung of animals. Additionally, siRNA knockdown of endogenous Ang2 in three human metastatic breast cancer cell lines also inhibits phosphorylation of Akt, expression of Bcl-2, and tumor cell survival, migration, and increases cell apoptosis. Since increased expression of Ang2 correlates with elevated potential of human breast cancer metastasis in clinic, our data underscore the importance that up-regulated Ang2 not only stimulates breast cancer growth and metastasis at late stages of the process, but is also critical at the initiating stages of metastases onset, thereby suggesting Ang2 as a promising therapeutic target for treating patients with metastatic breast cancer.     

miR-92在膀胱癌患者中的表达与膀胱癌细胞侵袭和耐药性的关系

为了考察miR-92在膀胱癌患者中的表达及与膀胱癌细胞侵袭和耐药性的关系,本研究通过RT-PCR检测了膀胱癌患者癌组织和BIU-87细胞中的miR-92表达,通过对BIU-87细胞转染miR-92抑制剂来敲低miR-92的表达。使用10μg/mL的顺铂处理BIU-87细胞24 h、48 h和72 h,Cell Counting Kit-8试剂盒(CCK-8)检测细胞活力。基质胶侵袭实验检测侵袭能力,Annexin V/PI流式细胞仪检测细胞凋亡。RT-PCR和Western blotting检测GSK3β、细胞核β-catenin、Cyclin D1、c-myc和MMP7的表达。研究显示,膀胱癌组织和细胞中miR-92的表达上调且与TNM分期和淋巴结转移相关。敲低miR-92抑制膀胱癌细胞增殖、侵袭和上皮-间质转化,并降低膀胱癌细胞的顺铂耐药性。敲低miR-92导致Cyclin D1、c-myc、MMP7和细胞核β-catenin的表达水平显著降低,而GSK3β的表达水平显著升高。本研究表明,miR-92在膀胱癌患者中明显上调,敲低miR-92可抑制膀胱癌细胞的增殖、转移和上皮-间质转化,并提高化疗药物敏感性。miR-92对膀胱癌细胞生物学行为的调控作用部分由Wnt信号通路相关分子(如GSK3β等)介导。     

膀胱癌中内皮素作用的研究

应用Ｎｏｒｔｈｅｒｎｂｌｏｔ杂交技术及放射免疫方法对人膀胱移行细胞癌组织中内皮素－１ｍＲＮＡ及内皮素活性分子的表达水平进行检测,研究了佛波酯对人膀胱移行细胞癌ＢＩＵ－８７细胞中内皮素活性分子表达水平的调节作用,并探讨了内皮素抗血清及内皮素Ａ型受体竞争性拮抗剂ＢＱ_（１２３）对ＢＩＵ－８７细胞ＤＮＡ合成的影响。结果表明,人膀胱移行细胞癌组织中内皮素－ｌｍＲＮＡ及内皮素活性分子的表达水平明显高于相应的癌旁组织,佛波酯可促进ＢＩＵ－８７细胞合成和分泌内皮素,内皮素抗血清及ＢＱ_（１２３）可抑制ＢＩＵ－８７细胞合成ＤＮＡ。提示内皮素在膀胱癌发展及ＢＩＵ－８７细胞恶性增殖中可能起重要作用。     

Exploring the five different genes associated with PKCα in bladder cancer based on gene expression microarray

Much progress has been made in understanding the mechanism of bladder cancer (BC) progression. Protein kinase C-α (PKCα) is overexpressed in many kinds of cancers. Additionally, PKCα is considered an oncogene that regulates proliferation, invasion, migration, apoptosis and cell cycle in multiple cancers. However, the mechanism underlying how these cellular processes are regulated by PKCα remains unknown. In the present study, we used PKCα siRNA to knock down PKCα gene expression and found that down-regulation of PKCα could significantly inhibit cell proliferation, migration and invasion and induce apoptosis and G1/S cell cycle arrest in vitro. Overexpression of PKCα promotes tumour growth in vivo. We applied cDNA microarray technology to detect the differential gene expression in J82 cells with PKCα knockdown and found that five key genes (BIRC2, BIRC3, CDK4, TRAF1 and BMP4) were involved in proliferation and apoptosis according to GO analysis and pathway analyses. Correlation analysis revealed a moderate positive correlation between PKCα expression and the expression of five downstream genes. BIRC2 and BIRC3 inhibit apoptosis, whereas CDK4, TRAF1 and BMP4 promote proliferation. Essentially, all five of these target genes participated in proliferation, and apoptosis was regulated by PKCα via the NF-kB signalling pathway.     

MicroRNA-145 directly targets the insulin-like growth factor receptor I in human bladder cancer cells

The insulin-like growth factor receptor I (IGF-IR) is a proto-oncogene with potent mitogenic and antiapoptotic activities. It has been reported that expression of IGF-IR is up-regulated in bladder cancer. Here, we assessed whether microRNA-145 (miR-145) regulates IGF-IR expression in bladder cancer. In our study, miR-145 was shown to directly target IGF-IR 3′-untranslated region (UTR) in human bladder cancer cells. Small interfering RNA (siRNA)- and miR-145-mediated IGF-IR knockdown experiments revealed that miR-145 promotes cell apoptosis, and suppresses cell proliferation and migration through suppression of IGF-IR expression. Taken together, our data suggest that miR-145 may inhibit bladder cancer initiation by affecting IGF-IR signaling.     

Silencing of the integrin-linked kinase gene suppresses the proliferation, migration and invasion of pancreatic cancer cells (Panc-1)

Integrin-linked kinase (ILK) is an ankyrin repeat-containing serine-threonine protein kinase that is involved in the regulation of integrin-mediated processes such as cancer cell proliferation, migration and invasion. In this study, we examined the effect of a lentivirus-mediated knockdown of ILK on the proliferation, migration and invasion of pancreatic cancer (Panc-1) cells. Immunohistochemical staining showed that ILK expression was enhanced in pancreatic cancer tissue. The silencing of ILK in human Panc-1 cells led to cell cycle arrest in the G0/G1 phase and delayed cell proliferation, in addition to down-regulating cell migration and invasion. The latter effects were mediated by up-regulating the expression of E-cadherin, a key protein in cell adhesion. These findings indicate that ILK may be a new diagnostic marker for pancreatic cancer and that silencing ILK could be a potentially useful therapeutic approach for treating pancreatic cancer.     

A new PKCα/β/TBX3/E-cadherin pathway is involved in PLCε-regulated invasion and migration in human bladder cancer cells

Although PLCε has been verified to enhance bladder cancer cell invasion, the signaling pathways responsible for this remain elusive. Protein kinase C (PKCα/β), which is involved in cancer development and progression, has been demonstrated to be activated by PLCε. However, the roles of PKCα/β in PLCε-mediated bladder carcinoma cell invasion and migration have not been clearly identified. In this study, to determine what role PKCα/β plays in PLCε-mediated bladder cancer cell invasion and migration, we silenced PLCε gene by adenovirus-shPLCε in T24 and BIU-87 cells and then revealed that it significantly inhibited cell migration and invasion. Further research indicated that cell bio-function of PLCε-regulated was related with PKCα/β activity. These in vitro findings were supported by data from bladder carcinoma patient samples. In 35 case bladder cancer tumor samples, PLCε-overexpressing tumors showed significantly higher positive rates of PKCα/β membrane immunohistochemistry staining than PLCε-low-expressing tumors. Mechanistically, study further showed that PLCε knockdown gene induced E-cadherin expression and decreased TBX3 expression, both of which were dependent on PKCα/β activity. In addition, we demonstrated that treatment cells with TBX3-specific shorting hairpin RNA (shRNA) up-regulated E-cadherin expression and inhibited cell invasion/migration. Moreover, in in vivo experiment, immunohistochemistry analysis of Ad-shPLCε-infected tumor tissue showed low expression levels of phospho-PKCα/β and TBX3 and high expression levels of E-cadherin compared with those of the control group. In summary, our findings uncover that PKCα/β is critical for PLCε-mediated cancer cell invasion and migration and provide valuable insights for current and future Ad-shPLCε and PKCα/β clinical trials.     

人膀胱癌中某些癌基因的研究

本实验应用Northern和斑点印渍杂交技术探测了人膀胱癌细胞株中c-myc、c-fos、erbB等癌基因的表达,以及TPA对这些癌基因表达的调控,发现BIU-87细胞有这些癌基因的表达,并能被TPA所增强,同时也发现人膀胱癌组织有c-myc、c-fos、erbB、N-ras基因的高表达。提示蛋白激酶C的激活可以诱导某些癌基因的表达。多种癌基因的表达异常可能在膀胱癌中起重要作用。     

探寻肝再生磷酸酶3在膀胱癌细胞T24中的作用

目的：已经有研究证明肝再生磷酸酶3（PhosphataseofRegeneratingLiver-3,PRL-3）在消化道肿瘤的发生发展过程中起到重要作用,但其在膀胱癌中发挥何种作用尚不清楚,本次研究主要探寻PRL-3在膀胱癌细胞T24中作用,以求为膀胱癌的治疗提供新思路。方法：采用siRNA干涉的方法下调T24中PRL-3蛋白表达水平,通过westernblot方法检测干涉效果,绘制细胞生长曲线、构建裸鼠种植瘤模型,检测PRL-3下调对细胞体外及体内增殖的影响。结果：我们所设计的siRNA能够下调PRL-3在A498细胞中的表达（F=7．26,P〈0．05）,细胞生长曲线显示下调PRL-3能够抑制细胞的增殖,这种作用从干涉后的第60h开始,随时间增加作用愈加明显（F≥8．35,P〈0．05）;动物实验表明,siRNA下调PRL-3能够抑制T24细胞在活体内的增殖,从干涉后第21天开始这种作用开始体现出来（F≥10．46,P〈0．05）,并且干涉组的肿瘤肿瘤明显低于两个对照组（F=13．63,P〈0．05）。结论：我们构建的siRNA能够在T24细胞中实现对PRL．3蛋白的下调,siRNA介导的PRL-3蛋白下调能够明显抑制T24细胞在活体外及活体内的增殖,这初步证明PRL-3在膀胱癌中发挥重要的作用。随着我们对PRL-3分子进一步深入的了解,揭示其发挥作用的具体机制,PRL-3很可能成为膀胱癌基因治疗的新靶点。     

骨形成蛋白9对人膀胱癌BIU-87细胞增殖和迁移的影响

目的:人骨形成蛋白9(bone morphogenetic protein 9,BMP9)对人膀胱癌BIU-87细胞增殖和迁移的影响。方法:使用过表达BMP9基因的腺病毒(AdBMP9)感染BIU-87细胞,采用定量PCR检测BMP9 mRNA的表达,Western blot检测BMP9蛋白及BMP9下游相关信号通路蛋白的表达;MTT及集落形成实验检测BIU-87细胞增殖能力;划痕愈合实验及Transwell ^TM小室迁移实验检测BIU-87细胞迁移能力。结果:感染AdBMP9后,BIU-87细胞中BMP9的mRNA水平和蛋白质水平均显著增加;过表达BMP9后,BIU-87细胞的体外增殖和迁移能力明显增加;Western blot结果显示BMP9可明显激活AKT信号通路。结论:高表达BMP9可能通过激活AKT信号通路促进人膀胱癌BIU-87细胞的增殖和迁移。     

The enhanced expression of estrogen-related receptor α in human bladder cancer tissues and the effects of estrogen-related receptor α knockdown on bladder cancer cells

Estrogen-related receptor α (ERRα) belongs to the superfamily of nuclear orphan receptors. However, the role of ERRα in bladder cancer remains unknown. This study examined the expression of ERRα in bladder cancer tissues and explored the molecular mechanisms of ERRα in bladder cancer progression. The expression of ERRα in bladder cancer tissues from 61 patients was determined by immunohistochemistry. We performed quantitative real-time polymerase chain reaction assay to detect the gene expression levels and carried out Western blot assay to measure protein levels. In vitro functional assays, including colony formation, Cell Counting Kit-8, Transwell invasion, and migration assays, were performed to detect bladder cancer cell growth, proliferation, invasion, and migration, respectively. Flow cytometry was used to determine the cell apoptotic rate of bladder cancer cells. Among the 61 detected bladder cancer tissues, 39 bladder cancer tissues showed positive ERRα immunoreactivity. Higher ERRα immunoreactivity score was significantly associated with TNM stage, tumor grade, distant metastasis, and poor survival in patients with bladder cancer. Univariate and multivariate analyses showed that ERRα immunoreactivity was an independent prognostic factor for overall survival in patients with bladder cancer. ERRα was found to be upregulated in bladder cancer cell lines, and knockdown of ERRα suppressed bladder cancer cell growth, proliferation, invasion, and migration; promoted bladder cancer cell apoptosis; and inhibited the epithelial-mesenchymal transition of bladder cancer cells. On the other hand, bladder cancer cell proliferation, invasion, and migration were significantly enhanced after cells were transfected with an ERRα-overexpressing vector. In vivo tumor growth and metastasis assays showed that ERRα knockdown resulted in remarkable inhibition of tumor growth and tumor metastasis in nude mice. Collectively, our results suggest that the enhanced expression of ERRα may play a key role in the development and progression of bladder cancer and ERRα may serve as an important prognostic factor for bladder cancer.     

Integrin-linked kinase tunes cell–cell and cell-matrix adhesions to regulate the switch between apoptosis and EMT downstream of TGFβ1

Epithelial-mesenchymal transition (EMT) is a morphogenetic process that endows epithelial cells with migratory and invasive potential. Mechanical and chemical signals from the tumor microenvironment can activate the EMT program, thereby permitting cancer cells to invade the surrounding stroma and disseminate to distant organs. Transforming growth factor β1 (TGFβ1) is a potent inducer of EMT that can also induce apoptosis depending on the microenvironmental context. In particular, stiff microenvironments promote EMT while softer ones promote apoptosis. Here, we investigated the molecular signaling downstream of matrix stiffness that regulates the phenotypic switch in response to TGFβ1 and uncovered a critical role for integrin-linked kinase (ILK). Specifically, depleting ILK from mammary epithelial cells precludes their ability to sense the stiffness of their microenvironment. In response to treatment with TGFβ1, ILK-depleted cells undergo apoptosis on both soft and stiff substrata. We found that knockdown of ILK decreases focal adhesions and increases cell–cell adhesions, thus shifting the balance from cell–matrix to cell–cell adhesion. High cell–matrix adhesion promotes EMT whereas high cell–cell adhesion promotes apoptosis downstream of TGFβ1. These results highlight an important role for ILK in controlling cell phenotype by regulating adhesive connections to the local microenvironment.     

某些肿瘤组织中血管内皮生长因子基因的表达

血管内皮生长因子(vascular endothelial growth factors,VEGF)是新发现的生长因子,特异作用于血管内皮细胞,促进其增殖及新生血管的生成.已确认,它和实体肿瘤的生长有着十分密切的关系.文章报道,利用力子杂交技术分析了胃癌、肾癌、结肠癌和膀胱癌及其癌旁相应组织中VEGF mRNA的表达,结果发现,癌组织较其癌旁组织中vEGF mRNA的表达增高.SGC-7901细胞加TPA 4h后则明显促进VEGF mRNA的表达.转染含人反义N-ras₁ DNA片段重组质粒的人膀胱癌BIU-87细胞系可抑制VEGFmRNA表达.